RT Journal Article
SR Electronic
T1 3d virtual histology reveals pathological alterations of cerebellar granule cells in multiple sclerosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.07.22280811
DO 10.1101/2022.10.07.22280811
A1 Frost, Jakob
A1 Schmitzer, Bernhard
A1 Töpperwien, Mareike
A1 Eckermann, Marina
A1 Franz, Jonas
A1 Stadelmann, Christine
A1 Salditt, Tim
YR 2022
UL http://medrxiv.org/content/early/2022/10/10/2022.10.07.22280811.abstract
AB We investigate structural properties of neurons in the granular layer of human cerebellum with respect to their involvement in multiple sclerosis (MS). To this end we analyze data recorded by X-ray phase contrast tomography from tissue samples collected post mortem from a MS and a healthy control group. Using automated segmentation and histogram analysis based on optimal transport theory (OT) we find that the distributions representing nuclear structure in the granular layer move to a more compact nuclear state, i.e. smaller, denser and more heterogeneous nuclei in MS. We have previously made a similar observation for neurons of the dentate gyrus in Alzheimer’s disease, suggesting that more compact structure of neuronal nuclei which we attributed to increased levels of heterochromatin, may possibly represent a more general phenomenon of cellular senescence associated with neurodegeneration.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDeutsche Forschungsgemeinschaft (DFG, German Research Foundation) project CRC 1456/ A03, CRC 274/1 Project ID 408885537 B01, DFG Sta 1389/5-1, EXC 2067/1-390729940.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the University Medical Center Goettingen, headed by Prof. Dr. Juergen Brockmoeller. Positive decision dated 20.8.2020.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.